Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C2H5O4S.Na |
| Molecular Weight | 148.113 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].OCCS([O-])(=O)=O
InChI
InChIKey=LADXKQRVAFSPTR-UHFFFAOYSA-M
InChI=1S/C2H6O4S.Na/c3-1-2-7(4,5)6;/h3H,1-2H2,(H,4,5,6);/q;+1/p-1
| Molecular Formula | C2H5O4S |
| Molecular Weight | 125.124 |
| Charge | -1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | Na |
| Molecular Weight | 22.98976928 |
| Charge | 1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Identification of a κ-opioid agonist as a potent and selective lead for drug development against human African trypanosomiasis. | 2010-11-15 |
|
| Enucleation following treatment with intravenous pentamidine for Acanthamoeba sclerokeratitis. | 2010-10-05 |
|
| Effects of taurine on male reproduction in rats of different ages. | 2010-08-24 |
|
| Effect of beta-alanine treatment on mitochondrial taurine level and 5-taurinomethyluridine content. | 2010-08-24 |
|
| Highly efficient procedure for the synthesis of fructone fragrance using a novel carbon based acid. | 2010-08-05 |
|
| Diverse effects on mitochondrial and nuclear functions elicited by drugs and genetic knockdowns in bloodstream stage Trypanosoma brucei. | 2010-05-04 |
|
| Antileishmanial high-throughput drug screening reveals drug candidates with new scaffolds. | 2010-05-04 |
|
| Drug resistance in leishmaniasis. | 2010-05 |
|
| Treatment strategies for mucocutaneous leishmaniasis. | 2010-05 |
|
| Isethionate formation from taurine in Chromohalobacter salexigens: purification of sulfoacetaldehyde reductase. | 2010-05 |
|
| Bisbenzamidine derivative, pentamidine represses DNA damage response through inhibition of histone H2A acetylation. | 2010-02-09 |
|
| Incorporation of ionic ligands accelerates drug release from LDI-glycerol polyurethanes. | 2010-01 |
|
| Identification of potent chemotypes targeting Leishmania major using a high-throughput, low-stringency, computationally enhanced, small molecule screen. | 2009-11-03 |
|
| East African trypanosomiasis in a pregnant traveler. | 2009-11 |
|
| Leishmania killicki imported from Tunisian desert. | 2009-11 |
|
| Rapid modification of proteins using a rapamycin-inducible tobacco etch virus protease system. | 2009-10-15 |
|
| Drugs associated with more suicidal ideations are also associated with more suicide attempts. | 2009-10-02 |
|
| Genotypic status of the TbAT1/P2 adenosine transporter of Trypanosoma brucei gambiense isolates from Northwestern Uganda following melarsoprol withdrawal. | 2009-09-29 |
|
| Cutaneous and mucocutaneous leishmaniasis in Tigray, northern Ethiopia: clinical aspects and therapeutic concerns. | 2009-07 |
|
| Interventions for American cutaneous and mucocutaneous leishmaniasis. | 2009-04-15 |
|
| Effect of free versus liposomal-complexed pentamidine isethionate on biological characteristics of Acanthamoeba castellanii in vitro. | 2009-03 |
|
| In leishmaniasis due to Leishmania guyanensis infection, distinct intralesional interleukin-10 and Foxp3 mRNA expression are associated with unresponsiveness to treatment. | 2009-02-15 |
|
| A controlled, randomized nonblinded clinical trial to assess the efficacy of amphotericin B deoxycholate as compared to pentamidine for the treatment of antimony unresponsive visceral leishmaniasis cases in Bihar, India. | 2009-02 |
|
| Evaluation of treatment with pentamidine for cutaneous leishmaniasis in Suriname. | 2009-01 |
|
| Electrochemical synthesis of polyaniline nano-networks on p-aminobenzene sulfonic acid functionalized glassy carbon electrode Its use for the simultaneous determination of ascorbic acid and uric acid. | 2008-12-01 |
|
| The blood-brain barrier significantly limits eflornithine entry into Trypanosoma brucei brucei infected mouse brain. | 2008-11 |
|
| Blood collection from the American horseshoe crab, Limulus polyphemus. | 2008-10-13 |
|
| Diffuse skin spread of HIV-associated visceral leishmaniasis: cumbersome diagnostic and therapeutic issues. | 2008-10 |
|
| Anionic selectivity sequence of the Cl(-)-H+ symporter in the synaptosomal preparation from rat brain cortex. | 2008-08 |
|
| Effect of mesoionic 4-phenyl-5-(cinnamoyl)-1,3,4-thiadiazolium-2-phenylamine chloride derivative salts on the activities of the nitric oxide synthase and arginase of Leishmania amazonensis. | 2008-06 |
|
| Using the zebrafish lateral line to screen for ototoxicity. | 2008-06 |
|
| Pentamidine dosage: a base/salt confusion. | 2008-05-28 |
|
| Transporter-mediated GABA responses in horizontal and bipolar cells of zebrafish retina. | 2008-04-30 |
|
| Comparative efficacy assessment of pentamidine isethionate and diminazene aceturate in the chemotherapy of Trypanosoma brucei brucei infection in dogs. | 2008-02-14 |
|
| Characterizing the effect of pentamidine isethionate on the immune system using mouse splenocytes as an experimental model. | 2007-10 |
|
| Recurrent American cutaneous leishmaniasis. | 2007-09 |
|
| The DUF81 protein TauE in Cupriavidus necator H16, a sulfite exporter in the metabolism of C2 sulfonates. | 2007-09 |
|
| Cellulose biosynthesis pathway is a potential target in the improved treatment of Acanthamoeba keratitis. | 2007-05 |
|
| Why is sodium cocoyl isethionate (SCI) mild to the skin barrier? - An in vitro investigation based on the relative sizes of the SCI micelles and the skin aqueous pores. | 2007-03-06 |
|
| Depolarization evoked by acetylcholine in mesenteric arteries of hypertensive rats attenuates endothelium-dependent hyperpolarizing factor. | 2007-02 |
|
| Cl- channels of the distal nephron. | 2006-12 |
|
| [Efficacy and tolerance of pentamidine for treatment of cutaneous leishmaniasis caused by por L. (V) panamensis in Colombia]. | 2006-10 |
|
| Effect of polyvinylpyrrolidone and sodium lauroyl isethionate on kaolinite suspension in an aqueous phase. | 2006-08 |
|
| Development of a semi-automated colorimetric assay for screening anti-leishmanial agents. | 2006-07 |
|
| Efficacy of short-course intramuscular pentamidine isethionate treatment on Old World localized cutaneous leishmaniasis in 2 patients. | 2006-06-15 |
|
| Comparison between one and two injections of pentamidine isethionate, at 7 mg/kg in each injection, in the treatment of cutaneous leishmaniasis in French Guiana. | 2006-06 |
|
| Changes in composition of spider orb web sticky droplets with starvation and web removal, and synthesis of sticky droplet compounds. | 2006-04 |
|
| A diminazene-resistant strain of Trypanosoma brucei brucei isolated from a dog is cross-resistant to pentamidine in experimentally infected albino rats. | 2006-01 |
|
| Pentamidine is an antiparasitic and apoptotic drug that selectively modifies ubiquitin. | 2005-10 |
|
| Amidine derivatives and Leishmania amazonensis: an evaluation of the effect of nitric oxide (NO) production on the parasite-macrophage interaction. | 2005-02 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:29:45 GMT 2025
by
admin
on
Mon Mar 31 19:29:45 GMT 2025
|
| Record UNII |
3R36J71C17
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
124283
Created by
admin on Mon Mar 31 19:29:45 GMT 2025 , Edited by admin on Mon Mar 31 19:29:45 GMT 2025
|
PRIMARY | |||
|
1562-00-1
Created by
admin on Mon Mar 31 19:29:45 GMT 2025 , Edited by admin on Mon Mar 31 19:29:45 GMT 2025
|
PRIMARY | |||
|
3R36J71C17
Created by
admin on Mon Mar 31 19:29:45 GMT 2025 , Edited by admin on Mon Mar 31 19:29:45 GMT 2025
|
PRIMARY | |||
|
3R36J71C17
Created by
admin on Mon Mar 31 19:29:45 GMT 2025 , Edited by admin on Mon Mar 31 19:29:45 GMT 2025
|
PRIMARY | |||
|
5838
Created by
admin on Mon Mar 31 19:29:45 GMT 2025 , Edited by admin on Mon Mar 31 19:29:45 GMT 2025
|
PRIMARY | |||
|
517063
Created by
admin on Mon Mar 31 19:29:45 GMT 2025 , Edited by admin on Mon Mar 31 19:29:45 GMT 2025
|
PRIMARY | |||
|
DTXSID7027413
Created by
admin on Mon Mar 31 19:29:45 GMT 2025 , Edited by admin on Mon Mar 31 19:29:45 GMT 2025
|
PRIMARY | |||
|
216-343-6
Created by
admin on Mon Mar 31 19:29:45 GMT 2025 , Edited by admin on Mon Mar 31 19:29:45 GMT 2025
|
PRIMARY | |||
|
1364895
Created by
admin on Mon Mar 31 19:29:45 GMT 2025 , Edited by admin on Mon Mar 31 19:29:45 GMT 2025
|
PRIMARY | RxNorm | ||
|
Sodium 2-hydroxyethyl sulfonate
Created by
admin on Mon Mar 31 19:29:45 GMT 2025 , Edited by admin on Mon Mar 31 19:29:45 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
